Chi, K., Protheroe, A., Rodríguez-Antolín, A., Facchini, G., Suttman, H., Matsubara, N., … Fizazi, K. (2018). Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial. The Lancet. Oncology. https://doi.org/10.1016/S1470-2045(17)30911-7 (Original work published 2018)

Zhuo, M., Zheng, Q., Zhao, J., Wu, M., An, T., Wang, Y., … Wang, Z. (2017). Survival difference between <i>EGFR</i> Del19 and L858R mutant advanced non-small cell lung cancer patients receiving gefitinib: a propensity score matching analysis. Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu, 29(6), 553-560. https://doi.org/10.21147/j.issn.1000-9604.2017.06.10